Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADEPT feasibility study in primary care alcohol detoxification
2008-004820-22Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of acamprosate in alcohol dependence (2 arms), sponsored by University of Bristol. Primary endpoint: Feasibility of recruitment and trial conduct. Started Nov 2010; status: completed.
02
Drugs
acamprosate
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on 2008-004820-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004820-22.